AZN

Neutral

Palladiem LLC Invests $495,000 in Astrazeneca Plc $AZN

Palladiem LLC bought a new stake in Astrazeneca Plc (NYSE:AZN – Free Report) in the fourth quarter, according to the company in its most recent disclo...

watchlistnews 4 days ago 0

Neutral

Rathbones Group PLC Sells 4,200 Shares of Astrazeneca Plc $AZN

Rathbones Group PLC trimmed its position in Astrazeneca Plc (NYSE:AZN – Free Report) by 35.8% during the fourth quarter, Holdings Channel reports. The...

watchlistnews 2 weeks ago 0

Neutral

AstraZeneca (AZN) CEO granted 18,359 shares as performance award vests

AstraZeneca PLC's CEO, Pascal Soriot, received 18,359 ordinary shares after a performance share award from May 2021 vested on May 14, 2026. This award...

Stock Titan 3 weeks ago 0

Bullish

AstraZeneca plc stock (GB0009895292): oncology and vaccines stay in focus after latest earnings and pipeline updates

AstraZeneca plc remains a key player in global pharmaceuticals, with investors focusing on its first-quarter 2025 earnings and ongoing pipeline develo...

AD HOC NEWS 3 weeks ago 0

Bullish

AstraZeneca (AZN) secures US approval for first-in-class Baxfendy hypertension treatment

AstraZeneca has received US FDA approval for Baxfendy (baxdrostat), a first-in-class aldosterone synthase inhibitor, for adults with hypertension whos...

Stock Titan 3 weeks ago 0

Bullish

Enhertu gains early breast cancer approvals for AstraZeneca (NYSE: AZN) in US

AstraZeneca's Enhertu has received two new FDA approvals for HER2-positive early breast cancer in both neoadjuvant and adjuvant settings, based on str...

Stock Titan 3 weeks ago 0

Bullish

AstraZeneca PLC stock (US6549022043): FDA green light for Enhertu boosts oncology focus

AstraZeneca PLC has received another FDA approval for its cancer drug Enhertu, expanding its use in a breast cancer indication. This decision, followi...

AD HOC NEWS 3 weeks ago 0